Page 15 - GPD-4-3
P. 15

Gene & Protein in Disease                                      Targeting cathepsins during cancer development








































            Figure 2. Interplay between cathepsin protease (Cts) expression and apoptotic regulation. Cts expression and its movement through the secretory pathway
            typically result in its presence in perinuclear lysosomes. During Cts overexpression, as observed in cancer cells, it can localize in peripheral lysosomes
            (in addition to being secreted into the extracellular space). Here, cathepsin leakage from lysosomes upon lysosomal membrane permeabilization can lead
            to the cleavage of cytoplasmic Bcl-2 proteins, altered regulation of mitochondrial outer membrane permeabilization (MOMP), and caspase-dependent
                                                                                        159
            apoptosis of cells. The two main sites of cathepsin inhibition are marked by blue arrows. Adapted from Zamyatnin et al.  Copyright © 2023 Authors.
              Studies also link Cts expression in cancer stem cells   Table 2. Cathepsin proteases (Cts), their ECM target
            with disease progression. For instance, enhanced Cts B   proteins, and biological effects of Cts expression during
            and Cts D expression was detected in adenocarcinoma   cancer progression
            OCT4-positive  liver  metastases   and tongue  squamous   Cts  ECM target  Biological effects  References
                                      50
                    51
            stem cells.  Similarly, CD133-positive glioblastoma stem
            cells  were enriched with Cts B activity.          B, L, S  E-cadherin    Tumor invasiveness  44
               52
                                                               B     CD18             Angiogenesis      131
              Finally,  overexpression of  certain Cts  can  induce   S  Nidogen-1    Invasiveness/     132
            chemo-resistance in specific cancer cells, as seen with                   Angiogenesis
            Cts L expression. Knockdown of Cts L sensitized A549   S  Canesten/Arresten  Angiogenesis   133
            lung cancer  and BC cells 54,55  to the therapeutic effects of
                     53
            paclitaxel and cisplatin.                          B, L  Lam./Fibron./COL IV  Tumor invasiveness  134
                                                               B     Tenascin-C       Oncogenesis       135
              Collectively,  these  studies  highlight  the  importance   B, L, S  COL XVIII  Angiogenesis  136, 137
            of  Cts,  correlating  their  positive  expression  levels  with   K  Periostin  Breast cancer   138
            cancer invasiveness and their potential as biomarkers.                    metastases
            They also underscore the emerging role of Cts expression   K  SPARC       Bone metastases   139
            in chemotherapeutic resistance and the ongoing need for
            novel Cts-specific therapeutic designs.            Abbreviations: Lam: Laminin; Fibron: Fibronectin; COL: Collagen;
                                                               SPARC: Secreted protein acidic and rich in cysteine protein;
            3. Cts regulation and ECM dynamics                 ECM: Extracellular matrix.
            The collective effects of Cts expression on disease appear in   cytoplasmic compartments, where they modulate key
            various ways, particularly during cancer progression. Some   proteins involved in cell fate. Alternatively, they can be
            proteases are overexpressed and can leak into intracellular   secreted from cancer or stromal cells upon overexpression,


            Volume 4 Issue 3 (2025)                         4                               doi: 10.36922/gpd.4768
   10   11   12   13   14   15   16   17   18   19   20